EXPERIENCE

Chris’s areas of expertise include merger enforcement, interlocking directorates, joint ventures, compliance programs, and employee “no-poach” agreements. He has advised on cross-border investigations involving the European Union, the United Kingdom, Canada, Brazil, Japan, Korea and Saudi Arabia, among other jurisdictions, and has handled merger reviews and other antitrust matters involving multiple industries, including health insurance, transportation, telecommunications, technology, energy, agriculture and biotechnology.

Prior to his private practice, Chris was a trial attorney in the Transportation, Energy & Agriculture Section of the U.S. Department of Justice’s Antitrust Division. During his time in the Division, he managed or played a key role in numerous high-profile matters, including merger reviews for Halliburton-Baker Hughes, Aetna-Humana, Anthem-Cigna, Alaska Airlines-Virgin and CVS-Aetna. Chris received the Antitrust Division’s Award of Distinction on two separate occasions.

Chris’s notable representations include:

• Endeavor Energy Resources in its $26 billion merger with Diamondback Energy;
• Envestnet in its $4.5 billion take-private deal with Bain Capital;
• Pioneer Natural Resources in its $65 billion merger with ExxonMobil;
• Platinum Equity in its $5.25 billion acquisition of Solenis;
• GE Healthcare in its $1.45 billion acquisition of BK Medical;
• Xylem in its $7.5 billion acquisition of Evoqua;
• Spark Therapeutics in its $4.3 billion sale to Roche; and
• Stone Canyon Industries in its $3 billion acquisition of Morton Salt

​INDUSTRY AWARDS & RECOGNITIONS

Among other recognitions, Chris was recently included in the Lawdragon 500 Leading Global Antitrust & Competition Lawyers list. During his time at the Department of Justice, Chris was twice awarded the Antitrust Division’s Award of Distinction.

PROFESSIONAL AFFILIATIONS AND THOUGHT LEADERSHIP

Chris frequently writes and speaks on antitrust topics for numerous publications and podcasts, including Concurrences, Law360, the Curious Amalgam, and The Deal, among others. Chris has also been published in numerous antitrust newsletters and publications.

While at Columbia Law School, Chris was a Harlan Fiske Stone scholar and served as an editor on the Columbia Business Law Review.